カテゴリー： QYResearch, 世界, 医療/バイオ

世界の静脈血栓塞栓症治療オプション市場インサイト及び予測（上部空気圧迫スリーブ、下部空気圧圧縮スリーブ、永久下大静脈フィルター、その他）

◆英語タイトル：Global Venous Thromboembolism Treatment Options Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JLX09303）◆商品コード：QY22JLX09303
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：94
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、静脈血栓塞栓症治療オプションのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に静脈血栓塞栓症治療オプションの世界市場のxxx％を占める「上部空気圧迫スリーブ」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
静脈血栓塞栓症治療オプションの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの静脈血栓塞栓症治療オプション市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

静脈血栓塞栓症治療オプションのグローバル主要企業には、AngioDynamics、Cardinal Health Inc.、BTG International Ltd.、Stryker Corporation、DJO Global Inc.、EKOS Corp、Teleflex Inc., Boston Scientific Corp.、Janssen Pharmaceuticals, Incなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

静脈血栓塞栓症治療オプション市場は、種類と用途によって区分されます。世界の静脈血栓塞栓症治療オプション市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
上部空気圧迫スリーブ、下部空気圧圧縮スリーブ、永久下大静脈フィルター、その他

【用途別セグメント】
病院、カテーテル検査室、外来手術センター

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 静脈血栓塞栓症治療オプション製品概要
- 種類別市場（上部空気圧迫スリーブ、下部空気圧圧縮スリーブ、永久下大静脈フィルター、その他）
- 用途別市場（病院、カテーテル検査室、外来手術センター）
- 調査の目的
・エグゼクティブサマリー
- 世界の静脈血栓塞栓症治療オプション販売量予測2017-2028
- 世界の静脈血栓塞栓症治療オプション売上予測2017-2028
- 静脈血栓塞栓症治療オプションの地域別販売量
- 静脈血栓塞栓症治療オプションの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別静脈血栓塞栓症治療オプション販売量
- 主要メーカー別静脈血栓塞栓症治療オプション売上
- 主要メーカー別静脈血栓塞栓症治療オプション価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（上部空気圧迫スリーブ、下部空気圧圧縮スリーブ、永久下大静脈フィルター、その他）
- 静脈血栓塞栓症治療オプションの種類別販売量
- 静脈血栓塞栓症治療オプションの種類別売上
- 静脈血栓塞栓症治療オプションの種類別価格
・用途別市場規模（病院、カテーテル検査室、外来手術センター）
- 静脈血栓塞栓症治療オプションの用途別販売量
- 静脈血栓塞栓症治療オプションの用途別売上
- 静脈血栓塞栓症治療オプションの用途別価格
・北米市場
- 北米の静脈血栓塞栓症治療オプション市場規模（種類別、用途別）
- 主要国別の静脈血栓塞栓症治療オプション市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの静脈血栓塞栓症治療オプション市場規模（種類別、用途別）
- 主要国別の静脈血栓塞栓症治療オプション市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の静脈血栓塞栓症治療オプション市場規模（種類別、用途別）
- 主要国別の静脈血栓塞栓症治療オプション市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の静脈血栓塞栓症治療オプション市場規模（種類別、用途別）
- 主要国別の静脈血栓塞栓症治療オプション市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの静脈血栓塞栓症治療オプション市場規模（種類別、用途別）
- 主要国別の静脈血栓塞栓症治療オプション市場規模（トルコ、サウジアラビア）
・企業情報
AngioDynamics、Cardinal Health Inc.、BTG International Ltd.、Stryker Corporation、DJO Global Inc.、EKOS Corp、Teleflex Inc., Boston Scientific Corp.、Janssen Pharmaceuticals, Inc
・産業チェーン及び販売チャネル分析
- 静脈血栓塞栓症治療オプションの産業チェーン分析
- 静脈血栓塞栓症治療オプションの原材料
- 静脈血栓塞栓症治療オプションの生産プロセス
- 静脈血栓塞栓症治療オプションの販売及びマーケティング
- 静脈血栓塞栓症治療オプションの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 静脈血栓塞栓症治療オプションの産業動向
- 静脈血栓塞栓症治療オプションのマーケットドライバー
- 静脈血栓塞栓症治療オプションの課題
- 静脈血栓塞栓症治療オプションの阻害要因
・主な調査結果

The most common treatment for deep vein thrombosis is the use of anticoagulants, also known as blood thinners. These medicines, which can be taken by injection or pill, can reduce your blood’s ability to clot. They don’t break down existing clots, but they prevent them from getting bigger and reduce the risk of more clots forming. Injectable drugs can be given either subcutaneously or intravenously.
Market Analysis and Insights: Global Venous Thromboembolism Treatment Options Market
Due to the COVID-19 pandemic, the global Venous Thromboembolism Treatment Options market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Upper Pneumatic Compression Sleeves accounting for % of the Venous Thromboembolism Treatment Options global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Venous Thromboembolism Treatment Options market size is valued at US$ million in 2021, while the US and Europe Venous Thromboembolism Treatment Options are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Venous Thromboembolism Treatment Options landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Venous Thromboembolism Treatment Options include AngioDynamics, Cardinal Health Inc., BTG International Ltd., Stryker Corporation, DJO Global Inc., EKOS Corp, Teleflex Inc., Boston Scientific Corp. and Janssen Pharmaceuticals, Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Venous Thromboembolism Treatment Options Scope and Segment
Venous Thromboembolism Treatment Options market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Venous Thromboembolism Treatment Options market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Upper Pneumatic Compression Sleeves
Lower Pneumatic Compression Sleeves
Permanent Inferior Vena Cava Filters
Others
Segment by Application
Hospitals
Catheterisation Laboratories
Ambulatory Surgical Centers
By Company
AngioDynamics
Cardinal Health Inc.
BTG International Ltd.
Stryker Corporation
DJO Global Inc.
EKOS Corp
Teleflex Inc., Boston Scientific Corp.
Janssen Pharmaceuticals, Inc
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Venous Thromboembolism Treatment Options Product Introduction
1.2 Market by Type
1.2.1 Global Venous Thromboembolism Treatment Options Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Upper Pneumatic Compression Sleeves
1.2.3 Lower Pneumatic Compression Sleeves
1.2.4 Permanent Inferior Vena Cava Filters
1.2.5 Others
1.3 Market by Application
1.3.1 Global Venous Thromboembolism Treatment Options Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Catheterisation Laboratories
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Venous Thromboembolism Treatment Options Sales Estimates and Forecasts 2017-2028
2.2 Global Venous Thromboembolism Treatment Options Revenue Estimates and Forecasts 2017-2028
2.3 Global Venous Thromboembolism Treatment Options Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Venous Thromboembolism Treatment Options Sales by Region
2.4.1 Global Venous Thromboembolism Treatment Options Sales by Region (2017-2022)
2.4.2 Global Sales Venous Thromboembolism Treatment Options by Region (2023-2028)
2.5 Global Venous Thromboembolism Treatment Options Revenue by Region
2.5.1 Global Venous Thromboembolism Treatment Options Revenue by Region (2017-2022)
2.5.2 Global Venous Thromboembolism Treatment Options Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Venous Thromboembolism Treatment Options Sales by Manufacturers
3.1.1 Global Top Venous Thromboembolism Treatment Options Manufacturers by Sales (2017-2022)
3.1.2 Global Venous Thromboembolism Treatment Options Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Venous Thromboembolism Treatment Options in 2021
3.2 Global Venous Thromboembolism Treatment Options Revenue by Manufacturers
3.2.1 Global Venous Thromboembolism Treatment Options Revenue by Manufacturers (2017-2022)
3.2.2 Global Venous Thromboembolism Treatment Options Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Venous Thromboembolism Treatment Options Revenue in 2021
3.3 Global Venous Thromboembolism Treatment Options Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Venous Thromboembolism Treatment Options Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Venous Thromboembolism Treatment Options Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Venous Thromboembolism Treatment Options Sales by Type
4.1.1 Global Venous Thromboembolism Treatment Options Historical Sales by Type (2017-2022)
4.1.2 Global Venous Thromboembolism Treatment Options Forecasted Sales by Type (2023-2028)
4.1.3 Global Venous Thromboembolism Treatment Options Sales Market Share by Type (2017-2028)
4.2 Global Venous Thromboembolism Treatment Options Revenue by Type
4.2.1 Global Venous Thromboembolism Treatment Options Historical Revenue by Type (2017-2022)
4.2.2 Global Venous Thromboembolism Treatment Options Forecasted Revenue by Type (2023-2028)
4.2.3 Global Venous Thromboembolism Treatment Options Revenue Market Share by Type (2017-2028)
4.3 Global Venous Thromboembolism Treatment Options Price by Type
4.3.1 Global Venous Thromboembolism Treatment Options Price by Type (2017-2022)
4.3.2 Global Venous Thromboembolism Treatment Options Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Venous Thromboembolism Treatment Options Sales by Application
5.1.1 Global Venous Thromboembolism Treatment Options Historical Sales by Application (2017-2022)
5.1.2 Global Venous Thromboembolism Treatment Options Forecasted Sales by Application (2023-2028)
5.1.3 Global Venous Thromboembolism Treatment Options Sales Market Share by Application (2017-2028)
5.2 Global Venous Thromboembolism Treatment Options Revenue by Application
5.2.1 Global Venous Thromboembolism Treatment Options Historical Revenue by Application (2017-2022)
5.2.2 Global Venous Thromboembolism Treatment Options Forecasted Revenue by Application (2023-2028)
5.2.3 Global Venous Thromboembolism Treatment Options Revenue Market Share by Application (2017-2028)
5.3 Global Venous Thromboembolism Treatment Options Price by Application
5.3.1 Global Venous Thromboembolism Treatment Options Price by Application (2017-2022)
5.3.2 Global Venous Thromboembolism Treatment Options Price Forecast by Application (2023-2028)
6 North America
6.1 North America Venous Thromboembolism Treatment Options Market Size by Type
6.1.1 North America Venous Thromboembolism Treatment Options Sales by Type (2017-2028)
6.1.2 North America Venous Thromboembolism Treatment Options Revenue by Type (2017-2028)
6.2 North America Venous Thromboembolism Treatment Options Market Size by Application
6.2.1 North America Venous Thromboembolism Treatment Options Sales by Application (2017-2028)
6.2.2 North America Venous Thromboembolism Treatment Options Revenue by Application (2017-2028)
6.3 North America Venous Thromboembolism Treatment Options Market Size by Country
6.3.1 North America Venous Thromboembolism Treatment Options Sales by Country (2017-2028)
6.3.2 North America Venous Thromboembolism Treatment Options Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Venous Thromboembolism Treatment Options Market Size by Type
7.1.1 Europe Venous Thromboembolism Treatment Options Sales by Type (2017-2028)
7.1.2 Europe Venous Thromboembolism Treatment Options Revenue by Type (2017-2028)
7.2 Europe Venous Thromboembolism Treatment Options Market Size by Application
7.2.1 Europe Venous Thromboembolism Treatment Options Sales by Application (2017-2028)
7.2.2 Europe Venous Thromboembolism Treatment Options Revenue by Application (2017-2028)
7.3 Europe Venous Thromboembolism Treatment Options Market Size by Country
7.3.1 Europe Venous Thromboembolism Treatment Options Sales by Country (2017-2028)
7.3.2 Europe Venous Thromboembolism Treatment Options Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Venous Thromboembolism Treatment Options Market Size by Type
8.1.1 Asia Pacific Venous Thromboembolism Treatment Options Sales by Type (2017-2028)
8.1.2 Asia Pacific Venous Thromboembolism Treatment Options Revenue by Type (2017-2028)
8.2 Asia Pacific Venous Thromboembolism Treatment Options Market Size by Application
8.2.1 Asia Pacific Venous Thromboembolism Treatment Options Sales by Application (2017-2028)
8.2.2 Asia Pacific Venous Thromboembolism Treatment Options Revenue by Application (2017-2028)
8.3 Asia Pacific Venous Thromboembolism Treatment Options Market Size by Region
8.3.1 Asia Pacific Venous Thromboembolism Treatment Options Sales by Region (2017-2028)
8.3.2 Asia Pacific Venous Thromboembolism Treatment Options Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Venous Thromboembolism Treatment Options Market Size by Type
9.1.1 Latin America Venous Thromboembolism Treatment Options Sales by Type (2017-2028)
9.1.2 Latin America Venous Thromboembolism Treatment Options Revenue by Type (2017-2028)
9.2 Latin America Venous Thromboembolism Treatment Options Market Size by Application
9.2.1 Latin America Venous Thromboembolism Treatment Options Sales by Application (2017-2028)
9.2.2 Latin America Venous Thromboembolism Treatment Options Revenue by Application (2017-2028)
9.3 Latin America Venous Thromboembolism Treatment Options Market Size by Country
9.3.1 Latin America Venous Thromboembolism Treatment Options Sales by Country (2017-2028)
9.3.2 Latin America Venous Thromboembolism Treatment Options Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Venous Thromboembolism Treatment Options Market Size by Type
10.1.1 Middle East and Africa Venous Thromboembolism Treatment Options Sales by Type (2017-2028)
10.1.2 Middle East and Africa Venous Thromboembolism Treatment Options Revenue by Type (2017-2028)
10.2 Middle East and Africa Venous Thromboembolism Treatment Options Market Size by Application
10.2.1 Middle East and Africa Venous Thromboembolism Treatment Options Sales by Application (2017-2028)
10.2.2 Middle East and Africa Venous Thromboembolism Treatment Options Revenue by Application (2017-2028)
10.3 Middle East and Africa Venous Thromboembolism Treatment Options Market Size by Country
10.3.1 Middle East and Africa Venous Thromboembolism Treatment Options Sales by Country (2017-2028)
10.3.2 Middle East and Africa Venous Thromboembolism Treatment Options Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AngioDynamics
11.1.1 AngioDynamics Corporation Information
11.1.2 AngioDynamics Overview
11.1.3 AngioDynamics Venous Thromboembolism Treatment Options Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AngioDynamics Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AngioDynamics Recent Developments
11.2 Cardinal Health Inc.
11.2.1 Cardinal Health Inc. Corporation Information
11.2.2 Cardinal Health Inc. Overview
11.2.3 Cardinal Health Inc. Venous Thromboembolism Treatment Options Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Cardinal Health Inc. Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cardinal Health Inc. Recent Developments
11.3 BTG International Ltd.
11.3.1 BTG International Ltd. Corporation Information
11.3.2 BTG International Ltd. Overview
11.3.3 BTG International Ltd. Venous Thromboembolism Treatment Options Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 BTG International Ltd. Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BTG International Ltd. Recent Developments
11.4 Stryker Corporation
11.4.1 Stryker Corporation Corporation Information
11.4.2 Stryker Corporation Overview
11.4.3 Stryker Corporation Venous Thromboembolism Treatment Options Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Stryker Corporation Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Stryker Corporation Recent Developments
11.5 DJO Global Inc.
11.5.1 DJO Global Inc. Corporation Information
11.5.2 DJO Global Inc. Overview
11.5.3 DJO Global Inc. Venous Thromboembolism Treatment Options Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 DJO Global Inc. Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 DJO Global Inc. Recent Developments
11.6 EKOS Corp
11.6.1 EKOS Corp Corporation Information
11.6.2 EKOS Corp Overview
11.6.3 EKOS Corp Venous Thromboembolism Treatment Options Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 EKOS Corp Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 EKOS Corp Recent Developments
11.7 Teleflex Inc., Boston Scientific Corp.
11.7.1 Teleflex Inc., Boston Scientific Corp. Corporation Information
11.7.2 Teleflex Inc., Boston Scientific Corp. Overview
11.7.3 Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Teleflex Inc., Boston Scientific Corp. Recent Developments
11.8 Janssen Pharmaceuticals, Inc
11.8.1 Janssen Pharmaceuticals, Inc Corporation Information
11.8.2 Janssen Pharmaceuticals, Inc Overview
11.8.3 Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Janssen Pharmaceuticals, Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Venous Thromboembolism Treatment Options Industry Chain Analysis
12.2 Venous Thromboembolism Treatment Options Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Venous Thromboembolism Treatment Options Production Mode & Process
12.4 Venous Thromboembolism Treatment Options Sales and Marketing
12.4.1 Venous Thromboembolism Treatment Options Sales Channels
12.4.2 Venous Thromboembolism Treatment Options Distributors
12.5 Venous Thromboembolism Treatment Options Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Venous Thromboembolism Treatment Options Industry Trends
13.2 Venous Thromboembolism Treatment Options Market Drivers
13.3 Venous Thromboembolism Treatment Options Market Challenges
13.4 Venous Thromboembolism Treatment Options Market Restraints
14 Key Findings in The Global Venous Thromboembolism Treatment Options Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の静脈血栓塞栓症治療オプション市場インサイト及び予測（上部空気圧迫スリーブ、下部空気圧圧縮スリーブ、永久下大静脈フィルター、その他）(Global Venous Thromboembolism Treatment Options Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 静脈手術消耗品のグローバル市場展望 2023年-2029年：静脈ステント、カテーテル、ガイドワイヤー、その他
  • 静脈性潰瘍用治療のグローバル市場予測2023-2029
  • 潰瘍性大腸炎治療オプションのグローバル市場2023年：抗炎症薬、免疫抑制剤、その他医薬品
  • 世界の医療用静脈血採取針市場インサイト及び予測（ホルダー付き、ホルダーなし）
  • 世界の静脈内留針市場インサイト及び予測（開放型留置針、閉鎖型留置針）